← Back to Search

Mesh

Group 2 - Ileal Conduit with Mesh for Parastomal Hernia

N/A
Waitlist Available
Led By Murugesan Manoharan, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 months
Awards & highlights

Summary

Concurrent placement of a mesh during formation of ileal conduit will decrease the incidence of parastomal hernia and associated complications.

Eligible Conditions
  • Parastomal Hernia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of Reduction of the Incidence of Parastomal Hernia
Secondary study objectives
Number of Participants Who Develop Mesh Related Complications

Trial Design

2Treatment groups
Active Control
Group I: Group 1 - Ideal Conduit No MeshActive Control1 Intervention
No mesh will be placed at the time of radical cystectomy and ileal conduit.
Group II: Group 2 - Ileal Conduit with MeshActive Control1 Intervention
Ethicon Physiomesh will be placed at the time of radical cystectomy and ileal conduit.

Find a Location

Who is running the clinical trial?

Ethicon, Inc.Industry Sponsor
92 Previous Clinical Trials
62,209 Total Patients Enrolled
University of MiamiLead Sponsor
945 Previous Clinical Trials
427,594 Total Patients Enrolled
Murugesan Manoharan, MDPrincipal InvestigatorUniversity of Miami
~1 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top